A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

She blamed irritable bowel syndrome, constipation and even a tight bra. Looking back, she had some classic symptoms of colon ...

Pfizer only picked up an accelerated approval from the FDA for its Braftovi-based combination regimen for colorectal cancer ...

Pharmaceutical giant GSK and the University of Oxford are collaborating on developing a cancer vaccine that aims to detect pre-cancer cells up to 20 years before they become malignant. This innovative ...

Doctors at Bhopal's Hamidia Hospital performed a historic surgery, creating a new stomach from the small intestine for a ...

The NHS doesn’t offer bowel screening until we’re 50. Yet with cancer rates rising, it may be worth forking out for a private ...

In most cases, the cause is something other than cancer. Learn more about bowel cancer. Seek professional guidance if any change in bowel movements has persisted for more than a few days.

New Delhi: The government may propose duty cuts in the Union budget for medicines imported to treat cancer and rare diseases, offering relief for patients burdened with the increasing cost of such ...

The target on JustGiving for the appeal devoted to research into this ultra rare form of cancer is £100,000. At the moment Desmoplastic Small Round Cell Tumour has no dedicated organisation fighting ...

Bowel cancer is the second-biggest cancer killer in the UK, and recent research suggests the risk of developing it is rising. Last year bowel cancer rates were reported to be rising more sharply ...

explained that the patient suffered from a condition called delayed vaginal vault dehiscence with small bowel prolapse and obstruction, which is extremely rare, affecting fewer than 0.1% of women ...

Get Instant Summarized Text (Gist) CD74 protein levels can predict immunotherapy response in bowel cancer, regardless of subtype. This discovery could expand treatment eligibility to patients with ...